i&i Prague

Bio-Innovation Center

We are the first choice partner and the leading institution for the best early-phase biotech innovations and smart money investments.

We are i&i Prague, a bio-innovation center located right in the heart of Europe. Our objective is to identify the potential of new inventions in Drug Discovery, Diagnostics, MedTech and other Life Science fields. We do this by scouting for innovative projects and investing in the most promising ones. Then we will help with product development and, ultimately, market entry.

We can help you with

Investment

With our investment, we try to help innovative ideas in their transition from research projects to functional companies.

Partnering

We are creating a unique network of partners that brings a long-term exchange of innovative ideas and original experiences.

Incubation

We are your new team member, leading your journey from groundbreaking invention to market-storming product.

Education

We offer exciting educational activities that introduce important topics connecting the worlds of science and business.

Excellence & Knowledge

We are the center of excellence and a knowledge base.

Commercalization Partner

We facilitate discussions between spin-offs and industry.

Complex Support

We are the center of complex support for the best of all projects.

Our role

Our portfolio

We focus on unique ideas that have the potential to succeed on a global scale. We are dedicated to innovations in Drug Discovery, Diagnostics, MedTech and other Life Science fields that originate from academic institutions.

i&i Biotech Fund I

In 2021, we established the i&i Biotech Fund I (i&i Bio) in cooperation with the European Investment Fund. i&i Bio is the venture capital firm that invests in innovative European Life Sciences companies focused on Drug Discovery, Diagnostics, MedTech and other Life Science fields.

Highlights

Dec 23, 2022

We are looking for new Antonin Holy and new drugs and diagnostics that can have a global impact and success

"i&i Bio invests in technology transfer with a strong focus on healthcare. We look for unique technologies that come from Czech and foreign science. We always try to find something new and unique, something that could bring great benefit to patients and also to our investors," says Jaromír Zahrádka for Fintag.cz. The podcast is in the Czech language.

Sep 28, 2022

Smart bandages not only capture pathogens, but also destroy them in no time. All they need is ordinary light.

Hospital-acquired infections are a problem that current technologies are not able to deal with effectively. However, this could change in the future; the Czech spin-off LAM-X a.s. is working on the development of a nanomaterial that not only passively prevents pathogens from entering open wounds, but can also actively destroy them...

Sep 13, 2022

CasInvent Pharma Raises €1.3 Million from KHAN-I and i&i Biotech Fund

CasInvent Pharma, an early-stage drug discovery company developing small-molecule compounds with anticancer properties, has raised an investment round of €1.3 million provided by KHAN-I and i&i Bio. With this funding, CasInvent will be strengthening its portfolio of CK inhibitors and progressing its lead compound to...

15

We have created or otherwise supported 15 spin-off companies from 5 countries.

We have an equity stake in 9 spin-offs. We have already announced our first exit.

1.8

Overall, the spin-offs in our portfolio have raised more than CZK 1.8 billion from other investors.

We have participatedin the sale of more than 10 licenses with a value exceeding CZK 5 million.

Where you can meet us

Our partners

To play, press and hold the enter key. To stop, release the enter key.